Director of Biochemistry Davis Joseph met with several Ministers of the Canadian Government. He had the chance to introduce and present them his 2 research breakthroughs including the Unified Theory of Neurodegeneration, that paves the way for new treatments for Alzheimer’s and Parkinson’s diseases. Some photos of the occasion are given below.
International Journal of Molecular Sciences MDPI

• Article 1: The Fundamental Neurobiological Mechanism of Oxidative Stress-Related 4E-BP2 Protein Deamidation - Accessed 10,000 times in the first 7 months of publication- a record for single author papers: https://flogen.com/Davis_Articles/Scientific and Financial Significance of Davis Joseph Neurodegeneration Papers.pdf
• Article 2: The Unified Theory of Neurodegeneration Pathogenesis Based on Axon Deamidation - Accessed 5,000 times in the first 3 months of publication- a record for single author papers: https://flogen.com/Davis_Articles/Uncovering New Mechanisms to Cure Neurodegenerative Disease - MDPI Blog.pdf

Both discovers and correspodn papers published have been covered by more than 1100 media around the world: https://lnkd.in/gXxKSmNN

Davis Joseph with the Honourable Rechie Valdez, Minister of Women and Gender Equality and Secretary of State (Small Business and Tourism)

Davis Joseph with the Honourable Steven Guilbeault, Minister of Canadian Identity and Culture and Minister responsible for Official Languages

Davis Joseph with the Honourable Sean Fraser, the Minister of Justice and Attorney General of Canada

Davis Joseph with the Honorable Mélanie Joly, Minister of Innovation, Science and Industry of Canada

Davis Joseph with the Honourable Evan Solomon, Minister of Artificial Intelligence and Digital Innovation and Minister responsible for the Federal Economic Development Agency for Southern Ontario, Canada

An insightful exchange took place between Davis Joseph, of FLOGEN Technologies Inc., and Dr. Emmanuelle Charpentier, 2020 Nobel Laureate in Chemistry. Their discussion touched on the challenges and breakthroughs in CRISPR gene-editing technology, the practical barriers to clinical application in diseases like cancer, and the evolving frontiers of genetic research.

Watch the full conversation below to explore how cutting-edge science is shaping the future of health and sustainability.

A great discussion between Davis Joseph & Emmanuelle Charpentier, 2020 Nobel Laureate in chemistry

FLOGEN CEO Dr. Florian Kongoli met with renowned Japanese rock guitarist Kyoji Yamamoto, an accomplished musician, singer-songwriter, and record producer, known for his long-standing career and continued vocal performance.

During the exchange, discussions highlighted TWENDEE MTCONTROL, a product developed by Dr. Haruhiko Inufusa (Gifu University, Japan) and supported by TIMA Japan, a partner of SIPS.

TWENDEE is designed to support cellular energy and reduce oxidative stress through a combination of vitamins, amino acids, and bioactive compounds. It has been used by professional musicians in Japan as part of long-term health routines aimed at maintaining performance, endurance, and vocal condition.

This interaction reflects the broader multidisciplinary scope of FLOGEN SIPS, where science, health, and innovation intersect to support human performance and well-being.